Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-04-23

FDA Approved: FLUVOXAMINE MALEATE — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved Actavis Pharma's original application for fluvoxamine maleate, a generic form of fluvoxamine for obsessive-compulsive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluvoxamine Maleate (Fluvoxamine maleate)

Snippet

ORIG AP for FLUVOXAMINE MALEATE (FLUVOXAMINE MALEATE)